| 1 | Maturity-onset diabetes of the young | Enrichment | HNF1B, INS, NEUROD1, PAX4, PDX1, PTF1A | 7.56 |
| 2 | Cleft upper lip | Enrichment | GJA1, IRF6, MSX1, TP63 | 7.36 |
| 3 | Type 2 diabetes mellitus | Enrichment | HNF1B, IL6, NEUROD1, PAX4, PDX1, SLC2A2 | 5.51 |
| 4 | Cleft lip and alveolus | Enrichment | IRF6, MSX1, TP63 | 5.44 |
| 5 | Cleft lip/palate | Enrichment | BMP4, IRF6, MSX1, TP63 | 5.09 |
| 6 | 46,xy partial gonadal dysgenesis | Enrichment | GATA4, OTX2, SOX9, WT1 | 5.09 |
| 7 | Macs syndrome | Enrichment | OTX2, PAX6, SHH, SOX2 | 4.42 |
| 8 | Permanent neonatal diabetes mellitus | Enrichment | INS, PDX1, STAT3 | 4.30 |
| 9 | Hypoplastic left heart syndrome | Enrichment | GJA1, NKX2-5, NOTCH1 | 4.30 |
| 10 | Ventricular septal defect | Enrichment | FOXF1, SMARCA4, TBX5 | 4.13 |
| 11 | Pancreas, dorsal, agenesis of | Enrichment | PDX1, PTF1A | 4.02 |
| 12 | Cardiomyopathy, dilated, 1ff | Enrichment | KLF5, TNNI3 | 4.02 |
| 13 | Bladder exstrophy | Enrichment | ISL1, TP63 | 4.02 |
| 14 | Papillary renal cell carcinoma | Enrichment | MET, MITF | 4.02 |
| 15 | Tetralogy of fallot | Enrichment | GATA4, KDR, NKX2-5, NOTCH1 | 3.95 |
| 16 | Atrial heart septal defect | Enrichment | NKX2-5, SMARCA4, TBX5 | 3.84 |
| 17 | Interatrial communication | Enrichment | NKX2-5, SMARCA4, TBX5 | 3.84 |
| 18 | Septooptic dysplasia | Enrichment | OTX2, SHH, SOX2 | 3.72 |
| 19 | Osteoporosis, juvenile | Enrichment | DKK1, WNT3A | 3.55 |
| 20 | Heart disease | Enrichment | GATA4, NKX2-5, TBX5 | 3.51 |
| 21 | Inherited cancer-predisposing syndrome | Enrichment | BMPR1A, EPCAM, MET, MITF, RUNX1, SMARCA4, WT1 | 3.50 |
| 22 | Aniridia 1 | Enrichment | PAX6, WT1 | 3.25 |
| 23 | Heart, malformation of | Enrichment | GATA4, NODAL, TBX5 | 3.17 |
| 24 | Patent foramen ovale | Enrichment | GATA4, NKX2-5, TBX5 | 3.17 |
| 25 | Microphthalmia | Enrichment | OTX2, PAX6, SOX2 | 2.91 |
| 26 | Wilms tumor, aniridia, genitourinary anomalies, and impaired intellectual development syndrome | Enrichment | PAX6, WT1 | 2.86 |
| 27 | Type 1 diabetes mellitus | Enrichment | IL6, INS | 2.86 |
| 28 | Anterior segment dysgenesis 5 | Enrichment | BMP4, PAX6 | 2.86 |
| 29 | Waardenburg syndrome, type 2e | Enrichment | KITLG, MITF | 2.71 |
| 30 | Familial isolated restrictive cardiomyopathy | Enrichment | TNNI3, TNNT2 | 2.71 |
| 31 | Basal ganglia calcification, idiopathic, 1 | Enrichment | PDGFB, PDGFRB | 2.59 |
| 32 | Myocarditis | Enrichment | TNNI3, TNNT2 | 2.59 |
| 33 | Combined pituitary hormone deficiency | Enrichment | FOXA2, OTX2 | 2.59 |
| 34 | Primary ovarian insufficiency | Enrichment | AFP, KDR, TP63, WT1 | 2.58 |
| 35 | Cardiomyopathy, familial hypertrophic, 4 | Enrichment | TNNI3, TNNT2 | 2.48 |
| 36 | Cystic fibrosis | Enrichment | CFTR, SERPINA1, TGFB1 | 2.43 |
| 37 | Peters-plus syndrome | Enrichment | BMP4, PAX6 | 2.39 |
| 38 | Left ventricular noncompaction | Enrichment | NKX2-5, TNNI3, TNNT2 | 2.32 |
| 39 | Nanophthalmos | Enrichment | OTX2, SOX2 | 2.31 |
| 40 | 46,xy complete gonadal dysgenesis | Enrichment | SOX9, WT1 | 2.31 |
| 41 | Meningioma | Enrichment | PDGFB, TERT | 2.23 |
| 42 | Restrictive cardiomyopathy | Enrichment | TNNI3, TNNT2 | 2.23 |
| 43 | Aortic valve disease 1 | Enrichment | NKX2-5, NOTCH1 | 2.16 |
| 44 | Microphthalmia/coloboma 12 | Enrichment | PAX2, PAX6 | 2.16 |
| 45 | Neural tube defects | Enrichment | ITGB1, TBXT | 2.16 |
| 46 | Leukemia, acute myeloid | Enrichment | GATA2, RUNX1, TERT | 2.16 |
| 47 | Dilated cardiomyopathy | Enrichment | NKX2-5, TBX5, TNNI3, TNNT2 | 2.10 |
| 48 | Aortic aneurysm, familial thoracic 1 | Enrichment | GATA4, NOTCH1 | 2.09 |
| 49 | Coloboma of macula | Enrichment | PAX2, PAX6 | 2.04 |
| 50 | Renal cell carcinoma, nonpapillary | Enrichment | HNF1B, MET | 2.04 |
| 51 | Lynch syndrome | Enrichment | CFTR, EPCAM | 2.04 |
| 52 | Septopreoptic holoprosencephaly | Enrichment | NODAL, SHH | 2.04 |
| 53 | Midline interhemispheric variant of holoprosencephaly | Enrichment | NODAL, SHH | 2.04 |
| 54 | Palmoplantar keratoderma and congenital alopecia 1 | Enrichment | GJA1 | 2.01 |
| 55 | Holoprosencephaly 3 | Enrichment | SHH | 2.01 |
| 56 | Rapp-hodgkin syndrome | Enrichment | TP63 | 2.01 |
| 57 | Cardiomyopathy, familial hypertrophic, 2 | Enrichment | TNNT2 | 2.01 |
| 58 | Ankyloblepharon-ectodermal defects-cleft lip/palate | Enrichment | TP63 | 2.01 |
| 59 | Chiari malformation type i | Enrichment | DKK1 | 2.01 |
| 60 | Atrial septal defect 7 with or without atrioventricular conduction defects | Enrichment | NKX2-5 | 2.01 |
| 61 | Pancreatic agenesis 1 | Enrichment | PDX1 | 2.01 |
| 62 | Hypoplastic left heart syndrome 1 | Enrichment | GJA1 | 2.01 |
| 63 | Stapes ankylosis with broad thumbs and toes | Enrichment | NOG | 2.01 |
| 64 | Tarsal-carpal coalition syndrome | Enrichment | NOG | 2.01 |
| 65 | Hypothyroidism, congenital, nongoitrous, 5 | Enrichment | NKX2-5 | 2.01 |
| 66 | Short stature, auditory canal atresia, mandibular hypoplasia, and skeletal abnormalities | Enrichment | GSC | 2.01 |
| 67 | Premature aging syndrome, penttinen type | Enrichment | PDGFRB | 2.01 |
| 68 | Anemia, congenital, nonspherocytic hemolytic, 9 | Enrichment | GATA1 | 2.01 |
| 69 | Thrombocytopenia, x-linked, with or without dyserythropoietic anemia | Enrichment | GATA1 | 2.01 |
| 70 | Split-hand/foot malformation 4 | Enrichment | TP63 | 2.01 |
| 71 | Maturity-onset diabetes of the young, type 4 | Enrichment | PDX1 | 2.01 |
| 72 | Thrombocytopenia with beta-thalassemia, x-linked | Enrichment | GATA1 | 2.01 |
| 73 | Hypomagnesemia 4, renal | Enrichment | EGF | 2.01 |
| 74 | Cardiomyopathy, dilated, 2a | Enrichment | TNNI3 | 2.01 |
| 75 | Diabetes mellitus, ketosis-prone | Enrichment | PAX4 | 2.01 |
| 76 | Ankyloblepharon filiforme adnatum and cleft palate | Enrichment | TP63 | 2.01 |
| 77 | Deafness, autosomal recessive 39 | Enrichment | HGF | 2.01 |
| 78 | Orofacial cleft 6 | Enrichment | IRF6 | 2.01 |
| 79 | Stargardt disease 4 | Enrichment | PROM1 | 2.01 |
| 80 | Cardiomyopathy, familial restrictive, 3 | Enrichment | TNNT2 | 2.01 |
| 81 | Polyposis syndrome, hereditary mixed, 2 | Enrichment | BMPR1A | 2.01 |
| 82 | Diarrhea 4, malabsorptive, congenital, with diabetes mellitus and combined pituitary hormone deficiency | Enrichment | NEUROG3 | 2.01 |
| 83 | Holt-oram syndrome | Enrichment | TBX5 | 2.01 |
| 84 | Brachydactyly, type b2 | Enrichment | NOG | 2.01 |
| 85 | Oculodentodigital dysplasia | Enrichment | GJA1 | 2.01 |
| 86 | Cardiomyopathy, familial hypertrophic, 7 | Enrichment | TNNI3 | 2.01 |
| 87 | Popliteal pterygium syndrome | Enrichment | IRF6 | 2.01 |
| 88 | Maturity-onset diabetes of the young, type 6 | Enrichment | NEUROD1 | 2.01 |
| 89 | Basal ganglia calcification, idiopathic, 5 | Enrichment | PDGFB | 2.01 |
| 90 | Heterochromia iridis | Enrichment | MITF | 2.01 |
| 91 | Hyperpigmentation with or without hypopigmentation, familial progressive | Enrichment | KITLG | 2.01 |
| 92 | Microphthalmia/coloboma 5 | Enrichment | SHH | 2.01 |
| 93 | Adult syndrome | Enrichment | TP63 | 2.01 |
| 94 | Tietz albinism-deafness syndrome | Enrichment | MITF | 2.01 |
| 95 | Prostate cancer, hereditary, 11 | Enrichment | HNF1B | 2.01 |
| 96 | Pancreatic and cerebellar agenesis | Enrichment | PTF1A | 2.01 |
| 97 | Myofibromatosis, infantile, 1 | Enrichment | PDGFRB | 2.01 |
| 98 | Symphalangism, proximal, 1a | Enrichment | NOG | 2.01 |
| 99 | Sacral agenesis with vertebral anomalies | Enrichment | TBXT | 2.01 |
| 100 | Macular dystrophy, retinal, 2 | Enrichment | PROM1 | 2.01 |
| 101 | Multiple synostoses syndrome 1 | Enrichment | NOG | 2.01 |
| 102 | Vesicoureteral reflux 3 | Enrichment | SOX17 | 2.01 |
| 103 | Whim syndrome 1 | Enrichment | CXCR4 | 2.01 |
| 104 | Hyperthyroxinemia, familial dysalbuminemic | Enrichment | ALB | 2.01 |
| 105 | Bone mineral density quantitative trait locus 17 | Enrichment | LGR4 | 2.01 |
| 106 | Atrioventricular septal defect 4 | Enrichment | GATA4 | 2.01 |
| 107 | Aplasia of lacrimal and salivary glands | Enrichment | FGF10 | 2.01 |
| 108 | Craniometaphyseal dysplasia, autosomal recessive | Enrichment | GJA1 | 2.01 |
| 109 | Alpha-fetoprotein, hereditary persistence of | Enrichment | AFP | 2.01 |
| 110 | 46,xy sex reversal 10 | Enrichment | SOX9 | 2.01 |
| 111 | Intellectual developmental disorder, x-linked 110 | Enrichment | FGF13 | 2.01 |
| 112 | Agammaglobulinemia 8b, autosomal recessive | Enrichment | TCF3 | 2.01 |
| 113 | Amegakaryocytic thrombocytopenia, congenital, 2 | Enrichment | THPO | 2.01 |
| 114 | Heterotaxy, visceral, 5, autosomal | Enrichment | NODAL | 2.01 |
| 115 | 46,xx sex reversal 2 | Enrichment | SOX9 | 2.01 |
| 116 | Anemia, x-linked, with or without neutropenia and/or platelet abnormalities | Enrichment | GATA1 | 2.01 |
| 117 | Lymphedema, primary, with myelodysplasia | Enrichment | GATA2 | 2.01 |
| 118 | Osteofibrous dysplasia | Enrichment | MET | 2.01 |
| 119 | Diarrhea 9 | Enrichment | WNT2B | 2.01 |
| 120 | Microphthalmia, syndromic 6 | Enrichment | BMP4 | 2.01 |
| 121 | Developmental and epileptic encephalopathy 90 | Enrichment | FGF13 | 2.01 |
| 122 | Orofacial cleft 11 | Enrichment | BMP4 | 2.01 |
| 123 | T-cell large granular lymphocyte leukemia | Enrichment | STAT3 | 2.01 |
| 124 | Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language | Enrichment | MEF2C | 2.01 |
| 125 | Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 | Enrichment | TP63 | 2.01 |
| 126 | Oculodentodigital dysplasia, autosomal recessive | Enrichment | GJA1 | 2.01 |
| 127 | Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness | Enrichment | MITF | 2.01 |
| 128 | Lacrimoauriculodentodigital syndrome 3 | Enrichment | FGF10 | 2.01 |
| 129 | Microphthalmia, syndromic 5 | Enrichment | OTX2 | 2.01 |
| 130 | Limb-mammary syndrome | Enrichment | TP63 | 2.01 |
| 131 | Deafness, autosomal recessive 97 | Enrichment | MET | 2.01 |
| 132 | Microvascular complications of diabetes 1 | Enrichment | VEGFA | 2.01 |
| 133 | Ovary adenocarcinoma | Enrichment | INHBA | 2.01 |
| 134 | Agammaglobulinemia 8a, autosomal dominant | Enrichment | TCF3 | 2.01 |
| 135 | Skin/hair/eye pigmentation, variation in, 7 | Enrichment | KITLG | 2.01 |
| 136 | Autism 9 | Enrichment | MET | 2.01 |
| 137 | Meacham syndrome | Enrichment | WT1 | 2.01 |
| 138 | Atrial septal defect 2 | Enrichment | GATA4 | 2.01 |
| 139 | Ventricular septal defect 3 | Enrichment | NKX2-5 | 2.01 |
| 140 | Immunodeficiency 21 | Enrichment | GATA2 | 2.01 |
| 141 | Premature ovarian failure 21 | Enrichment | TP63 | 2.01 |
| 142 | Basal ganglia calcification, idiopathic, 4 | Enrichment | PDGFRB | 2.01 |
| 143 | Pituitary hormone deficiency, combined, 6 | Enrichment | OTX2 | 2.01 |
| 144 | Hereditary thrombocytosis with transverse limb defect | Enrichment | THPO | 2.01 |
| 145 | Testicular anomalies with or without congenital heart disease | Enrichment | GATA4 | 2.01 |
| 146 | Lynch syndrome 8 | Enrichment | EPCAM | 2.01 |
| 147 | Alpha-fetoprotein deficiency | Enrichment | AFP | 2.01 |
| 148 | Myeloid and lymphoid neoplasms associated with pdgfrb rearrangement | Enrichment | PDGFRB | 2.01 |
| 149 | Alpha-1-antitrypsin deficiency | Enrichment | SERPINA1 | 2.01 |
| 150 | Retinitis pigmentosa 41 | Enrichment | PROM1 | 2.01 |
| 151 | Maturity-onset diabetes of the young, type 9 | Enrichment | PAX4 | 2.01 |
| 152 | Hypoplastic left heart syndrome 2 | Enrichment | NKX2-5 | 2.01 |
| 153 | Kosaki overgrowth syndrome | Enrichment | PDGFRB | 2.01 |
| 154 | Smarca4-deficient sarcoma of thorax | Enrichment | SMARCA4 | 2.01 |
| 155 | Ovarian small cell carcinoma | Enrichment | SMARCA4 | 2.01 |
| 156 | Orofacial cleft 8 | Enrichment | TP63 | 2.01 |
| 157 | Autoimmune disease, multisystem, infantile-onset, 1 | Enrichment | STAT3 | 2.01 |
| 158 | Irf6-related disorders | Enrichment | IRF6 | 2.01 |
| 159 | Autosomal dominant popliteal pterygium syndrome | Enrichment | IRF6 | 2.01 |
| 160 | 8p23.1 microdeletion syndrome | Enrichment | GATA4 | 2.01 |
| 161 | Erythrokeratodermia variabilis et progressiva 3 | Enrichment | GJA1 | 2.01 |
| 162 | Congenital analbuminemia | Enrichment | ALB | 2.01 |
| 163 | Deafness-lymphedema-leukemia syndrome | Enrichment | GATA2 | 2.01 |
| 164 | Ocular pterygium-digital keloid dysplasia syndrome | Enrichment | PDGFRB | 2.01 |
| 165 | Autosomal recessive dyskeratosis congenita 4 | Enrichment | TERT | 2.01 |
| 166 | Tufted angioma of skin | Enrichment | KDR | 2.01 |
| 167 | Deafness, autosomal dominant 69 | Enrichment | KITLG | 2.01 |
| 168 | Acute megakaryoblastic leukemia in children with down syndrome | Enrichment | GATA1 | 2.01 |
| 169 | Analbuminemia | Enrichment | ALB | 2.01 |
| 170 | Thrombocytopenia 9 | Enrichment | THPO | 2.01 |
| 171 | Arthrogryposis, distal, type 11 | Enrichment | MET | 2.01 |
| 172 | Immunodeficiency 125 | Enrichment | FLT3LG | 2.01 |
| 173 | Short-rib thoracic dysplasia 22 without polydactyly | Enrichment | FGF4 | 2.01 |
| 174 | Thrombocytopenia with congenital dyserythropoietic anemia | Enrichment | GATA1 | 2.01 |
| 175 | Pulmonary hypertension, primary, 7 | Enrichment | SOX17 | 2.01 |
| 176 | Non-acquired combined pituitary hormone deficiency | Enrichment | FOXA2 | 2.01 |
| 177 | Hemorrhagic disease due to alpha-1-antitrypsin pittsburgh mutation | Enrichment | SERPINA1 | 2.01 |
| 178 | Sacral agenesis-abnormal ossification of the vertebral bodies-persistent notochordal canal syndrome | Enrichment | TBXT | 2.01 |
| 179 | Sirenomelia | Enrichment | CDX2 | 2.01 |
| 180 | Stat3-related early-onset multisystem autoimmune disease | Enrichment | STAT3 | 2.01 |
| 181 | Tp63-related disorders | Enrichment | TP63 | 2.01 |
| 182 | 5q14.3 microdeletion syndrome | Enrichment | MEF2C | 2.01 |
| 183 | Aortic arch interruption | Enrichment | NKX2-5 | 2.01 |
| 184 | Aquagenic palmoplantar keratoderma | Enrichment | CFTR | 2.01 |
| 185 | Complete atrioventricular septal defect without ventricular hypoplasia | Enrichment | MEF2C | 2.01 |
| 186 | Atrial heart septal defect 7 | Enrichment | NKX2-5 | 2.01 |
| 187 | Partial atrioventricular septal defect with ventricular hypoplasia | Enrichment | GATA4 | 2.01 |
| 188 | Familial progressive hyperpigmentation | Enrichment | KITLG | 2.01 |
| 189 | Anorectal malformation | Enrichment | CDX2 | 2.01 |
| 190 | Pax2-related disorder | Enrichment | PAX2 | 2.01 |
| 191 | Medullary sponge kidney | Enrichment | HNF1B | 2.01 |
| 192 | Mef2c-related disorder | Enrichment | MEF2C | 2.01 |
| 193 | Renal dysplasia, bilateral | Enrichment | HNF1B | 2.01 |
| 194 | Premature aging | Enrichment | VIM | 2.01 |
| 195 | Unilateral multicystic dysplastic kidney | Enrichment | HNF1B | 2.01 |
| 196 | Renal dysplasia, unilateral | Enrichment | HNF1B | 2.01 |
| 197 | Chronic lymphoproliferative disorder of natural killer cells | Enrichment | STAT3 | 2.01 |
| 198 | Egf-related primary hypomagnesemia with intellectual disability | Enrichment | EGF | 2.01 |
| 199 | Familial progressive hyper- and hypopigmentation | Enrichment | KITLG | 2.01 |
| 200 | Autosomal dominant spondylocostal dysostosis | Enrichment | TBX6 | 2.01 |
| 201 | Interstitial lung disease specific to childhood | Enrichment | FGF10 | 2.01 |
| 202 | Microcephaly-polymicrogyria-corpus callosum agenesis syndrome | Enrichment | EOMES | 2.01 |
| 203 | Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome | Enrichment | SHH | 2.01 |
| 204 | Atresia of urethra | Enrichment | FOXF1 | 2.01 |
| 205 | Wolff-parkinson-white syndrome | Enrichment | NODAL, TNNT2 | 1.98 |
| 206 | Microform holoprosencephaly | Enrichment | NODAL, SHH | 1.98 |
| 207 | Lobar holoprosencephaly | Enrichment | NODAL, SHH | 1.98 |
| 208 | Thrombocytopenia | Enrichment | GATA1, RUNX1, THPO | 1.94 |
| 209 | Melanoma, cutaneous malignant 1 | Enrichment | MITF, TERT | 1.93 |
| 210 | Cleft palate, isolated | Enrichment | IRF6, SMARCA4 | 1.93 |
| 211 | Alobar holoprosencephaly | Enrichment | NODAL, SHH | 1.93 |
| 212 | Semilobar holoprosencephaly | Enrichment | NODAL, SHH | 1.88 |
| 213 | Focal segmental glomerulosclerosis | Enrichment | PAX2, WT1 | 1.79 |
| 214 | Ovarian cancer | Enrichment | BMPR1A, HNF1B, MET, WT1 | 1.76 |
| 215 | Hepatocellular carcinoma | Enrichment | MET, TERT | 1.71 |
| 216 | Tooth agenesis | Enrichment | IRF6, MSX1 | 1.71 |
| 217 | Keratitis, hereditary | Enrichment | PAX6 | 1.71 |
| 218 | Tubulointerstitial kidney disease, autosomal dominant 1 | Enrichment | HNF1B | 1.71 |
| 219 | Myeloproliferative syndrome, transient | Enrichment | GATA1 | 1.71 |
| 220 | Papillorenal syndrome | Enrichment | PAX2 | 1.71 |
| 221 | Burkitt lymphoma | Enrichment | MYC | 1.71 |
| 222 | Renal cysts and diabetes syndrome | Enrichment | HNF1B | 1.71 |
| 223 | Foveal hypoplasia 1 | Enrichment | PAX6 | 1.71 |
| 224 | Congenital anomalies of kidney and urinary tract 2 | Enrichment | HNF1B | 1.71 |
| 225 | Cardiomyopathy, familial restrictive, 1 | Enrichment | TNNI3 | 1.71 |
| 226 | Myeloproliferative disorder, chronic, with eosinophilia | Enrichment | PDGFRB | 1.71 |
| 227 | Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 1 | Enrichment | TP63 | 1.71 |
| 228 | Campomelic dysplasia | Enrichment | SOX9 | 1.71 |
| 229 | Otodental dysplasia | Enrichment | FGF3 | 1.71 |
| 230 | Camurati-engelmann disease 1 | Enrichment | TGFB1 | 1.71 |
| 231 | Fanconi-bickel syndrome | Enrichment | SLC2A2 | 1.71 |
| 232 | Storage pool platelet disease | Enrichment | RUNX1 | 1.71 |
| 233 | Thumb deformity | Enrichment | TBX5 | 1.71 |
| 234 | Denys-drash syndrome | Enrichment | WT1 | 1.71 |
| 235 | Agnathia-otocephaly complex | Enrichment | OTX2 | 1.71 |
| 236 | Spermatogenic failure, y-linked, 2 | Enrichment | CFTR | 1.71 |
| 237 | Porphyria, congenital erythropoietic | Enrichment | GATA1 | 1.71 |
| 238 | Pulmonary hypoplasia, primary | Enrichment | FGF10 | 1.71 |
| 239 | Dermatofibrosarcoma protuberans | Enrichment | PDGFB | 1.71 |
| 240 | Nephrotic syndrome, type 4 | Enrichment | WT1 | 1.71 |
| 241 | Rhabdoid tumor predisposition syndrome 2 | Enrichment | SMARCA4 | 1.71 |
| 242 | Deafness, congenital, with inner ear agenesis, microtia, and microdontia | Enrichment | FGF3 | 1.71 |
| 243 | Solitary median maxillary central incisor | Enrichment | SHH | 1.71 |
| 244 | Optic nerve hypoplasia, bilateral | Enrichment | PAX6 | 1.71 |
| 245 | Orofacial cleft 5 | Enrichment | MSX1 | 1.71 |
| 246 | Kallikrein, decreased urinary activity of | Enrichment | PTF1A | 1.71 |
| 247 | Frasier syndrome | Enrichment | WT1 | 1.71 |
| 248 | Adams-oliver syndrome 5 | Enrichment | NOTCH1 | 1.71 |
| 249 | Hallermann-streiff syndrome | Enrichment | GJA1 | 1.71 |
| 250 | Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 1 | Enrichment | TERT | 1.71 |
| 251 | Cardiomyopathy, familial hypertrophic, 25 | Enrichment | TNNI3 | 1.71 |
| 252 | Angioma, tufted | Enrichment | KDR | 1.71 |
| 253 | Maturity-onset diabetes of the young, type 10 | Enrichment | INS | 1.71 |
| 254 | Cardiomyopathy, dilated, 1dd | Enrichment | TNNT2 | 1.71 |
| 255 | Diarrhea 5, with tufting enteropathy, congenital | Enrichment | EPCAM | 1.71 |
| 256 | Witkop syndrome | Enrichment | MSX1 | 1.71 |
| 257 | Syndactyly, type iii | Enrichment | GJA1 | 1.71 |
| 258 | Syndactyly, type v | Enrichment | GJA1 | 1.71 |
| 259 | Cardiomyopathy, dilated, 1d | Enrichment | TNNT2 | 1.71 |
| 260 | Waardenburg syndrome, type 2f | Enrichment | KITLG | 1.71 |
| 261 | Hyperproinsulinemia | Enrichment | INS | 1.71 |
| 262 | Inflammatory bowel disease, immunodeficiency, and encephalopathy | Enrichment | TGFB1 | 1.71 |
| 263 | Infantile myofibromatosis | Enrichment | PDGFRB | 1.71 |
| 264 | Hyperuricemic nephropathy, familial juvenile, 3 | Enrichment | HNF1B | 1.71 |
| 265 | Melanoma, cutaneous malignant 8 | Enrichment | MITF | 1.71 |
| 266 | Childhood hepatocellular carcinoma | Enrichment | MET | 1.71 |
| 267 | Rhabdoid tumor predisposition syndrome | Enrichment | SMARCA4 | 1.71 |
| 268 | Craniometaphyseal dysplasia | Enrichment | GJA1 | 1.71 |
| 269 | Delayed puberty, self-limited | Enrichment | LGR4 | 1.71 |
| 270 | Acute basophilic leukemia | Enrichment | GATA1 | 1.71 |
| 271 | Focal segmental glomerulosclerosis 7 | Enrichment | PAX2 | 1.71 |
| 272 | Pyloric stenosis, infantile hypertrophic, 5 | Enrichment | FOXF1 | 1.71 |
| 273 | Cataract 30 | Enrichment | VIM | 1.71 |
| 274 | Central precocious puberty | Enrichment | DLK1 | 1.71 |
| 275 | Pancreatic agenesis 2 | Enrichment | PTF1A | 1.71 |
| 276 | Camurati-engelmann disease | Enrichment | TGFB1 | 1.71 |
| 277 | 46,xy sex reversal 3 | Enrichment | GATA4 | 1.71 |
| 278 | Diabetes mellitus, permanent neonatal, 4 | Enrichment | INS | 1.71 |
| 279 | Ciliary dyskinesia, primary, 43 | Enrichment | FOXJ1 | 1.71 |
| 280 | Melanoma, cutaneous malignant 9 | Enrichment | TERT | 1.71 |
| 281 | Otosclerosis 12 | Enrichment | SMARCA4 | 1.71 |
| 282 | Coffin-siris syndrome 4 | Enrichment | SMARCA4 | 1.71 |
| 283 | Aortic valve disease 2 | Enrichment | TBX5 | 1.71 |
| 284 | Proximal symphalangism | Enrichment | NOG | 1.71 |
| 285 | Idiopathic interstitial pneumonia | Enrichment | TERT | 1.71 |
| 286 | Congenital amegakaryocytic thrombocytopenia | Enrichment | THPO | 1.71 |
| 287 | Hereditary mixed polyposis syndrome | Enrichment | BMPR1A | 1.71 |
| 288 | Familial isolated congenital asplenia | Enrichment | NKX2-5 | 1.71 |
| 289 | Fissured tongue | Enrichment | TP63 | 1.71 |
| 290 | B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3) | Enrichment | TCF3 | 1.71 |
| 291 | Growth delay due to insulin-like growth factor type 1 deficiency | Enrichment | IGF1 | 1.71 |
| 292 | Deletion 5q35 | Enrichment | NKX2-5 | 1.71 |
| 293 | Van der woude syndrome | Enrichment | IRF6 | 1.71 |
| 294 | Renal hypoplasia, bilateral | Enrichment | PAX2 | 1.71 |
| 295 | B-lymphoblastic leukemia/lymphoma with t(17;19) | Enrichment | TCF3 | 1.71 |
| 296 | Juvenile polyposis of infancy | Enrichment | BMPR1A | 1.71 |
| 297 | Isolated radial hemimelia | Enrichment | SHH | 1.71 |
| 298 | Tafro syndrome | Enrichment | RUNX1 | 1.71 |
| 299 | Oculootodental syndrome | Enrichment | FGF3 | 1.71 |
| 300 | Desmoplastic small round cell tumor | Enrichment | WT1 | 1.71 |
| 301 | Idiopathic/heritable pulmonary arterial hypertension | Enrichment | FOXF1 | 1.71 |
| 302 | Campomelic dysplasia and related disorders | Enrichment | SOX9 | 1.71 |
| 303 | Cardiomyopathy, familial hypertrophic, 1 | Enrichment | TNNI3, TNNT2 | 1.64 |
| 304 | Familial atrial fibrillation | Enrichment | GATA4, NKX2-5 | 1.64 |
| 305 | Hyper-ige syndrome 1, autosomal dominant, with recurrent infections | Enrichment | STAT3 | 1.54 |
| 306 | Lacrimoauriculodentodigital syndrome 1 | Enrichment | FGF10 | 1.54 |
| 307 | Type 1 diabetes mellitus 2 | Enrichment | INS | 1.54 |
| 308 | Van der woude syndrome 1 | Enrichment | IRF6 | 1.54 |
| 309 | Mesothelioma, malignant | Enrichment | WT1 | 1.54 |
| 310 | Spondylocostal dysostosis 5 | Enrichment | TBX6 | 1.54 |
| 311 | Waardenburg syndrome, type 2a | Enrichment | MITF | 1.54 |
| 312 | Juvenile polyposis syndrome | Enrichment | BMPR1A | 1.54 |
| 313 | Thrombocythemia 1 | Enrichment | THPO | 1.54 |
| 314 | Gillespie syndrome | Enrichment | PAX6 | 1.54 |
| 315 | Syndactyly, type iv | Enrichment | SHH | 1.54 |
| 316 | Mullerian duct aplasia, unilateral renal agenesis, and cervicothoracic somite anomalies | Enrichment | HNF1B | 1.54 |
| 317 | 46,xx sex reversal 1 | Enrichment | SOX9 | 1.54 |
| 318 | Platelet disorder, familial, with associated myeloid malignancy | Enrichment | RUNX1 | 1.54 |
| 319 | Intellectual developmental disorder, x-linked 109 | Enrichment | SERPINA1 | 1.54 |
| 320 | Autoimmune disease 1 | Enrichment | FOXD3 | 1.54 |
| 321 | Nuchal bleb, familial | Enrichment | CFTR | 1.54 |
| 322 | Alveolar capillary dysplasia with misalignment of pulmonary veins | Enrichment | FOXF1 | 1.54 |
| 323 | Body mass index quantitative trait locus 12 | Enrichment | PCSK1 | 1.54 |
| 324 | Cone-rod dystrophy 12 | Enrichment | PROM1 | 1.54 |
| 325 | Dyskeratosis congenita, autosomal dominant 6 | Enrichment | THPO | 1.54 |
| 326 | Chromosome 17q12 deletion syndrome | Enrichment | HNF1B | 1.54 |
| 327 | Proprotein convertase 1/3 deficiency | Enrichment | PCSK1 | 1.54 |
| 328 | Breast implant-associated anaplastic large cell lymphoma | Enrichment | STAT3 | 1.54 |
| 329 | Hyper ige syndrome | Enrichment | STAT3 | 1.54 |
| 330 | High-grade b-cell lymphoma double-hit/triple-hit | Enrichment | MYC | 1.54 |
| 331 | Precocious puberty, central, 2 | Enrichment | DLK1 | 1.54 |
| 332 | Interstitial lung disease | Enrichment | TERT | 1.54 |
| 333 | Hypoplastic or aplastic tibia with polydactyly | Enrichment | SHH | 1.54 |
| 334 | Chromophobe renal cell carcinoma | Enrichment | HNF1B | 1.54 |
| 335 | Macrocytic anemia | Enrichment | TERT | 1.54 |
| 336 | Familial vesicoureteral reflux | Enrichment | SOX17 | 1.54 |
| 337 | Butterfly-shaped pigment dystrophy | Enrichment | OTX2 | 1.54 |
| 338 | Atypical juvenile parkinsonism | Enrichment | PODXL | 1.54 |
| 339 | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with runx1 | Enrichment | RUNX1 | 1.54 |
| 340 | Renal cell carcinoma | Enrichment | MET | 1.54 |
| 341 | Keratoacanthoma | Enrichment | NOTCH1 | 1.54 |
| 342 | Long qt syndrome 1 | Enrichment | SLC2A2, TBX5 | 1.46 |
| 343 | Kaposi sarcoma | Enrichment | IL6 | 1.41 |
| 344 | Ehlers-danlos syndrome, arthrochalasia type, 1 | Enrichment | ALB | 1.41 |
| 345 | Polydactyly, preaxial ii | Enrichment | SHH | 1.41 |
| 346 | Robinow syndrome, autosomal dominant 1 | Enrichment | WNT5A | 1.41 |
| 347 | Chordoma | Enrichment | TBXT | 1.41 |
| 348 | Down syndrome | Enrichment | GATA1 | 1.41 |
| 349 | Microphthalmia, syndromic 3 | Enrichment | SOX2 | 1.41 |
| 350 | Schizencephaly | Enrichment | SHH | 1.41 |
| 351 | Kagami-ogata syndrome | Enrichment | DLK1 | 1.41 |
| 352 | Temple syndrome | Enrichment | DLK1 | 1.41 |
| 353 | Multiple synostoses syndrome | Enrichment | NOG | 1.41 |
| 354 | Neonatal diabetes mellitus | Enrichment | INS | 1.41 |
| 355 | Lung sarcomatoid carcinoma | Enrichment | TERT | 1.41 |
| 356 | Blood platelet disease | Enrichment | RUNX1 | 1.41 |
| 357 | Idiopathic bronchiectasis | Enrichment | CFTR | 1.41 |
| 358 | Autosomal dominant robinow syndrome | Enrichment | WNT5A | 1.41 |
| 359 | Hereditary progressive cardiac conduction defect | Enrichment | NKX2-5 | 1.41 |
| 360 | Eyelid coloboma | Enrichment | PAX6 | 1.41 |
| 361 | Vacterl association | Enrichment | FOXF1 | 1.41 |
| 362 | Mitral valve insufficiency | Enrichment | TBX5 | 1.41 |
| 363 | Genetic central precocious puberty in male | Enrichment | DLK1 | 1.41 |
| 364 | Transposition of the great arteries | Enrichment | GATA4 | 1.41 |
| 365 | Systemic-onset juvenile idiopathic arthritis | Enrichment | IL6 | 1.41 |
| 366 | Haddad syndrome | Enrichment | ASCL1 | 1.41 |
| 367 | Clear cell papillary renal cell carcinoma | Enrichment | MITF | 1.41 |
| 368 | Lens coloboma | Enrichment | PAX6 | 1.41 |
| 369 | Connective tissue disease | Enrichment | NOTCH1, SOX9 | 1.41 |
| 370 | Familial hypertrophic cardiomyopathy | Enrichment | TNNI3, TNNT2 | 1.38 |
| 371 | Cakut | Enrichment | HNF1B, PAX2 | 1.36 |
| 372 | Genetic steroid-resistant nephrotic syndrome | Enrichment | PAX2, WT1 | 1.36 |
| 373 | Vater/vacterl association | Enrichment | FOXF1 | 1.32 |
| 374 | Robinow syndrome, autosomal recessive 1 | Enrichment | WNT5A | 1.32 |
| 375 | Parkinson disease 2, autosomal recessive juvenile | Enrichment | PODXL | 1.32 |
| 376 | Rheumatoid arthritis, systemic juvenile | Enrichment | IL6 | 1.32 |
| 377 | Atrioventricular septal defect | Enrichment | TBX5 | 1.32 |
| 378 | Insulin-like growth factor i | Enrichment | IGF1 | 1.32 |
| 379 | Leber congenital amaurosis 10 | Enrichment | WT1 | 1.32 |
| 380 | Ventricular septal defect 1 | Enrichment | GATA4 | 1.32 |
| 381 | Congenital heart defects, multiple types, 4 | Enrichment | GATA4 | 1.32 |
| 382 | Histiocytoid hemangioma | Enrichment | VIM | 1.32 |
| 383 | Nonsyndromic 46,xx testicular disorders/differences of sex development | Enrichment | SOX9 | 1.32 |
| 384 | Parkin type of early-onset parkinson disease | Enrichment | PODXL | 1.32 |
| 385 | Acute megakaryocytic leukemia | Enrichment | GATA1 | 1.32 |
| 386 | Aniridia | Enrichment | PAX6 | 1.32 |
| 387 | Coloboma of choroid and retina | Enrichment | PAX6 | 1.32 |
| 388 | Aggressive systemic mastocytosis | Enrichment | RUNX1 | 1.32 |
| 389 | Acute myeloid leukemia with t(8;21)(q22;q22) translocation | Enrichment | RUNX1 | 1.32 |
| 390 | Persistent truncus arteriosus | Enrichment | NKX2-5 | 1.32 |
| 391 | Primary hypereosinophilic syndrome | Enrichment | PDGFRB | 1.32 |
| 392 | Generalized juvenile polyposis/juvenile polyposis coli | Enrichment | BMPR1A | 1.32 |
| 393 | Idiopathic aplastic anemia | Enrichment | TERT | 1.32 |
| 394 | Colorectal cancer | Enrichment | EPCAM, MET, SOX9 | 1.27 |
| 395 | Cerebral palsy | Enrichment | PDGFRB, SMARCA4 | 1.25 |
| 396 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | GJA1, HGF, MET | 1.24 |
| 397 | Atrial septal defect 1 | Enrichment | TBX5 | 1.24 |
| 398 | Dyskeratosis congenita, autosomal dominant 1 | Enrichment | TERT | 1.24 |
| 399 | Coloboma of optic nerve | Enrichment | PAX6 | 1.24 |
| 400 | Conotruncal heart malformations | Enrichment | NKX2-5 | 1.24 |
| 401 | Pierre robin syndrome | Enrichment | SOX9 | 1.24 |
| 402 | Testicular germ cell tumor | Enrichment | KITLG | 1.24 |
| 403 | Waardenburg syndrome, type 4a | Enrichment | MITF | 1.24 |
| 404 | Wilms tumor 5 | Enrichment | WT1 | 1.24 |
| 405 | Hemangioma, capillary infantile | Enrichment | KDR | 1.24 |
| 406 | Anxiety | Enrichment | OTX2 | 1.24 |
| 407 | Congenital anomalies of kidney and urinary tract 1 | Enrichment | PAX2 | 1.24 |
| 408 | Inflammatory bowel disease 25, autosomal recessive | Enrichment | TGFB1 | 1.24 |
| 409 | Autosomal recessive robinow syndrome | Enrichment | WNT5A | 1.24 |
| 410 | Renal hypoplasia | Enrichment | PAX2 | 1.24 |
| 411 | Pancytopenia | Enrichment | RUNX1 | 1.24 |
| 412 | Diarrhea | Enrichment | WNT2B | 1.24 |
| 413 | Pulmonary fibrosis | Enrichment | TERT | 1.24 |
| 414 | Adrenocortical carcinoma | Enrichment | TERT | 1.24 |
| 415 | Double outlet right ventricle | Enrichment | NKX2-5 | 1.24 |
| 416 | Hoyeraal-hreidarsson syndrome | Enrichment | TERT | 1.24 |
| 417 | Il10-related early-onset inflammatory bowel disease | Enrichment | TGFB1 | 1.24 |
| 418 | Spondylocostal dysostosis, autosomal recessive | Enrichment | TBX6 | 1.24 |
| 419 | Waardenburg syndrome | Enrichment | MITF | 1.24 |
| 420 | Kidney clear cell sarcoma | Enrichment | TERT | 1.24 |
| 421 | Hypertrophic cardiomyopathy | Enrichment | TNNI3, TNNT2 | 1.18 |
| 422 | Waardenburg syndrome, type 1 | Enrichment | MITF | 1.18 |
| 423 | Hypothyroidism, congenital, nongoitrous, 2 | Enrichment | NKX2-5 | 1.18 |
| 424 | Leukemia, chronic myeloid | Enrichment | RUNX1 | 1.18 |
| 425 | Renal cell carcinoma, papillary, 1 | Enrichment | MET | 1.18 |
| 426 | Dyskeratosis congenita, autosomal dominant 2 | Enrichment | TERT | 1.18 |
| 427 | Adams-oliver syndrome | Enrichment | NOTCH1 | 1.18 |
| 428 | Essential thrombocythemia | Enrichment | THPO | 1.18 |
| 429 | Arthrogryposis, distal, type 1a | Enrichment | MET | 1.12 |
| 430 | Erythrokeratodermia variabilis et progressiva 1 | Enrichment | GJA1 | 1.12 |
| 431 | Leber congenital amaurosis 1 | Enrichment | PROM1 | 1.12 |
| 432 | Neuroblastoma | Enrichment | SMARCA4 | 1.12 |
| 433 | Isolated split hand-split foot malformation | Enrichment | TP63 | 1.12 |
| 434 | Difference of sex development | Enrichment | WT1 | 1.12 |
| 435 | Tooth agenesis, selective, 1 | Enrichment | MSX1 | 1.07 |
| 436 | Orofacial cleft 1 | Enrichment | FGF10 | 1.07 |
| 437 | Bronchiectasis with or without elevated sweat chloride 1 | Enrichment | CFTR | 1.07 |
| 438 | Vas deferens, congenital bilateral aplasia of | Enrichment | CFTR | 1.07 |
| 439 | Inflammatory bowel disease 1 | Enrichment | IL6 | 1.07 |
| 440 | Leukemia, acute lymphoblastic 3 | Enrichment | WT1 | 1.07 |
| 441 | Atypical chronic myeloid leukemia, bcr-abl1 negative | Enrichment | RUNX1 | 1.07 |
| 442 | Adult hepatocellular carcinoma | Enrichment | EGF | 1.07 |
| 443 | Cystic kidney disease | Enrichment | PAX2 | 1.07 |
| 444 | Colonic benign neoplasm | Enrichment | EPCAM | 1.07 |
| 445 | Rare autosomal dominant non-syndromic sensorineural deafness type dfna | Enrichment | KITLG, MITF | 1.04 |
| 446 | Cat eye syndrome | Enrichment | PAX6 | 1.03 |
| 447 | Cataract 30, multiple types | Enrichment | VIM | 1.03 |
| 448 | Lynch syndrome 1 | Enrichment | EPCAM | 1.03 |
| 449 | Aplastic anemia | Enrichment | TERT | 1.03 |
| 450 | Stickler syndrome | Enrichment | BMP4 | 1.03 |
| 451 | Melanoma | Enrichment | MITF | 1.03 |
| 452 | Autosomal non-syndromic agammaglobulinemia | Enrichment | TCF3 | 1.03 |
| 453 | Familial isolated dilated cardiomyopathy | Enrichment | TNNI3, TNNT2 | 1.02 |
| 454 | Meningioma, familial | Enrichment | PDGFB | 0.99 |
| 455 | Myelodysplastic syndrome | Enrichment | GATA2 | 0.99 |
| 456 | Diabetes mellitus | Enrichment | INS | 0.99 |
| 457 | Heritable pulmonary arterial hypertension | Enrichment | SOX17 | 0.99 |
| 458 | Familial colorectal cancer type x | Enrichment | BMPR1A | 0.99 |
| 459 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | Enrichment | CFTR, GATA4 | 0.98 |
| 460 | Renal hypodysplasia/aplasia 3 | Enrichment | BMP4 | 0.95 |
| 461 | Early-onset parkinson's disease | Enrichment | PODXL | 0.95 |
| 462 | Congenital long qt syndrome | Enrichment | SLC2A2 | 0.95 |
| 463 | Hypercholesterolemia, familial, 1 | Enrichment | SMARCA4 | 0.92 |
| 464 | Pulmonary hypertension, primary, 1 | Enrichment | SOX17 | 0.92 |
| 465 | Pulmonary disease, chronic obstructive | Enrichment | SERPINA1 | 0.92 |
| 466 | Acute promyelocytic leukemia | Enrichment | STAT3 | 0.92 |
| 467 | Premature menopause | Enrichment | TP63 | 0.92 |
| 468 | Protein-deficiency anemia | Enrichment | GATA1 | 0.92 |
| 469 | Lung cancer susceptibility 3 | Enrichment | FGF10 | 0.89 |
| 470 | Generalized epilepsy with febrile seizures plus | Enrichment | FGF13 | 0.89 |
| 471 | Hereditary chronic pancreatitis | Enrichment | CFTR | 0.89 |
| 472 | Isolated macular dystrophy | Enrichment | PROM1 | 0.89 |
| 473 | Coffin-siris syndrome 1 | Enrichment | SMARCA4 | 0.86 |
| 474 | Wilms tumor 1 | Enrichment | WT1 | 0.86 |
| 475 | Hydrocephalus | Enrichment | PDGFRB | 0.86 |
| 476 | Anterior segment dysgenesis | Enrichment | PAX6 | 0.86 |
| 477 | Familial hypercholesterolemia | Enrichment | SMARCA4 | 0.86 |
| 478 | Kidney disease | Enrichment | WT1 | 0.86 |
| 479 | Male infertility with spermatogenesis disorder | Enrichment | TP63 | 0.86 |
| 480 | Pancreatitis, hereditary | Enrichment | CFTR | 0.81 |
| 481 | Interstitial lung disease 2 | Enrichment | TERT | 0.81 |
| 482 | Dandy-walker syndrome | Enrichment | PDGFRB | 0.81 |
| 483 | Sudden infant death syndrome | Enrichment | TNNI3 | 0.81 |
| 484 | Arteriovenous malformations of the brain | Enrichment | IL6 | 0.77 |
| 485 | Diffuse large b-cell lymphoma | Enrichment | STAT3 | 0.77 |
| 486 | Dyskeratosis congenita | Enrichment | TERT | 0.77 |
| 487 | Cardiomyopathy, dilated, 1a | Enrichment | TNNI3 | 0.73 |
| 488 | Hepatoblastoma | Enrichment | TERT | 0.73 |
| 489 | Visceral heterotaxy | Enrichment | NODAL | 0.71 |
| 490 | Diamond-blackfan anemia 1 | Enrichment | GATA1 | 0.69 |
| 491 | Precursor t-cell acute lymphoblastic leukemia | Enrichment | MYC | 0.69 |
| 492 | Ear malformation | Enrichment | MITF | 0.68 |
| 493 | Scoliosis | Enrichment | TBX6 | 0.68 |
| 494 | Leber plus disease | Enrichment | OTX2, PROM1 | 0.62 |
| 495 | Bladder cancer | Enrichment | TERT | 0.60 |
| 496 | Prostate cancer | Enrichment | HNF1B | 0.60 |
| 497 | Differentiated thyroid carcinoma | Enrichment | TERT | 0.60 |
| 498 | Stargardt disease 1 | Enrichment | PROM1 | 0.59 |
| 499 | Visceral heterotaxy 5 | Enrichment | NODAL | 0.58 |
| 500 | Lung cancer | Enrichment | MET | 0.57 |
| 501 | Usher syndrome | Enrichment | PROM1 | 0.56 |
| 502 | Male infertility | Enrichment | CFTR | 0.55 |
| 503 | Diamond-blackfan anemia | Enrichment | GATA1 | 0.52 |
| 504 | Non-syndromic genetic deafness | Enrichment | MITF | 0.52 |
| 505 | Nonsyndromic hearing loss | Enrichment | MITF | 0.47 |
| 506 | Gastric cancer | Enrichment | EPCAM | 0.46 |
| 507 | Nephrotic syndrome | Enrichment | PAX2 | 0.46 |
| 508 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | NOTCH1 | 0.45 |
| 509 | Hereditary breast carcinoma | Enrichment | EPCAM | 0.45 |
| 510 | Sensorineural hearing loss | Enrichment | HGF | 0.42 |
| 511 | Body mass index quantitative trait locus 11 | Enrichment | PCSK1 | 0.41 |
| 512 | Hypertelorism | Enrichment | PAX6 | 0.40 |
| 513 | Hereditary breast ovarian cancer syndrome | Enrichment | MITF | 0.38 |
| 514 | Myeloma, multiple | Enrichment | TCF3 | 0.37 |
| 515 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 | Enrichment | MEF2C | 0.36 |
| 516 | Cone-rod dystrophy 2 | Enrichment | PROM1 | 0.31 |
| 517 | Autism | Enrichment | SHH | 0.29 |
| 518 | Breast cancer | Enrichment | EPCAM | 0.28 |
| 519 | Primary ciliary dyskinesia | Enrichment | FOXJ1 | 0.28 |
| 520 | Rare genetic deafness | Enrichment | MITF | 0.27 |
| 521 | Hereditary retinal dystrophy | Enrichment | NEUROD1, PAX2, PROM1 | 0.26 |
| 522 | Fundus dystrophy | Enrichment | NEUROD1, PAX2, PROM1 | 0.26 |
| 523 | Autism spectrum disorder | Enrichment | MEF2C | 0.18 |
| 524 | Retinitis pigmentosa | Enrichment | PROM1 | 0.06 |